New England Eye Center, Tufts Medical Center, Boston, Mass.
Can J Ophthalmol. 2013 Dec;48(6):535-8. doi: 10.1016/j.jcjo.2013.05.010.
To analyze the effect of focal laser photocoagulation on choroidal thickness in patients with diabetic macular edema (DME), using spectral-domain optical coherence tomography (SD-OCT).
Retrospective review.
Twenty-two eyes of 22 patients diagnosed with DME and treated with focal laser photocoagulation (treatment group) and 19 fellow treatment-naive eyes (control group) who underwent high-definition 1-line raster scanning using the Cirrus SD-OCT at the New England Eye Center, Tufts Medical Center (Boston, Mass.) between November 2009 and April 2012.
The SD-OCT images were analyzed for the measurement of choroidal thickness by 2 independent observers experienced in analyzing OCT images, before treatment and at 3 months after focal laser photocoagulation in the treatment group, and at baseline (when the fellow eye in the treatment group was treated) and at 3-month follow-up in the control group.
There was no significant difference in the mean choroidal thickness in the treatment and control groups (n = 22, p = 0.93 and n = 19, p = 0.1, respectively) at 3-month follow-up. There was no significant association of the number of focal laser treatments with the mean choroidal thickness (n = 41, r = -0.31, p = 0.68).
Focal laser photocoagulation does not appear to alter choroidal thickness in eyes with DME in the short term, as assessed using SD-OCT. Long-term follow-up of eyes with DME and other retinal diseases treated with laser photocoagulation may provide further insight into the effects of this treatment modality on the choroid.
使用频域光相干断层扫描(SD-OCT)分析激光光凝治疗糖尿病性黄斑水肿(DME)患者脉络膜厚度的效果。
回顾性研究。
2009 年 11 月至 2012 年 4 月,在新英格兰眼科中心(马萨诸塞州波士顿),使用 Cirrus SD-OCT 对 Tufts 医疗中心的 22 例 DME 患者的 22 只眼(治疗组)和 19 只未经激光光凝治疗的对侧眼(对照组)进行了高清 1 线光栅扫描,这些患者均被诊断为 DME 并接受了激光光凝治疗(治疗组),其中 2 名观察者具有丰富的 OCT 图像分析经验。对 SD-OCT 图像进行分析,以测量脉络膜厚度,分别在治疗前和治疗后 3 个月时测量治疗组的脉络膜厚度,在对照组中,在治疗组的对侧眼治疗时测量基线值(即对照组),并在治疗后 3 个月时进行随访。
分别在治疗前和治疗后 3 个月时测量治疗组的脉络膜厚度,在对照组中,在治疗组的对侧眼治疗时测量基线值(即对照组),并在治疗后 3 个月时进行随访。
在治疗组和对照组中,在 3 个月的随访时,两组的平均脉络膜厚度均无显著差异(n = 22,p = 0.93 和 n = 19,p = 0.1)。激光光凝治疗的次数与平均脉络膜厚度之间无显著相关性(n = 41,r = -0.31,p = 0.68)。
在短期随访中,使用 SD-OCT 评估,激光光凝治疗似乎不会改变 DME 眼的脉络膜厚度。对接受激光光凝治疗的 DME 眼和其他视网膜疾病的长期随访可能会进一步深入了解这种治疗方式对脉络膜的影响。